Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1994 Sep;72(3 Suppl):S61–S64. doi: 10.1136/hrt.72.3_suppl.s61

Insights from animal models of myocardial infarction: do ACE inhibitors limit the structural response?

Jos F M Smits 1,2, Mat J A P Daemen 1,2
PMCID: PMC1025595  PMID: 7946806

Full text

PDF
S61

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anversa P., Beghi C., Kikkawa Y., Olivetti G. Myocardial response to infarction in the rat. Morphometric measurement of infarct size and myocyte cellular hypertrophy. Am J Pathol. 1985 Mar;118(3):484–492. [PMC free article] [PubMed] [Google Scholar]
  2. Anversa P., Fitzpatrick D., Argani S., Capasso J. M. Myocyte mitotic division in the aging mammalian rat heart. Circ Res. 1991 Oct;69(4):1159–1164. doi: 10.1161/01.res.69.4.1159. [DOI] [PubMed] [Google Scholar]
  3. Capasso J. M., Bruno S., Cheng W., Li P., Rodgers R., Darzynkiewicz Z., Anversa P. Ventricular loading is coupled with DNA synthesis in adult cardiac myocytes after acute and chronic myocardial infarction in rats. Circ Res. 1992 Dec;71(6):1379–1389. doi: 10.1161/01.res.71.6.1379. [DOI] [PubMed] [Google Scholar]
  4. Chapman D., Weber K. T., Eghbali M. Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium. Circ Res. 1990 Oct;67(4):787–794. doi: 10.1161/01.res.67.4.787. [DOI] [PubMed] [Google Scholar]
  5. Cohn J. N., Archibald D. G., Ziesche S., Franciosa J. A., Harston W. E., Tristani F. E., Dunkman W. B., Jacobs W., Francis G. S., Flohr K. H. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986 Jun 12;314(24):1547–1552. doi: 10.1056/NEJM198606123142404. [DOI] [PubMed] [Google Scholar]
  6. Cooper G., 4th, Mercer W. E., Hoober J. K., Gordon P. R., Kent R. L., Lauva I. K., Marino T. A. Load regulation of the properties of adult feline cardiocytes. The role of substrate adhesion. Circ Res. 1986 May;58(5):692–705. doi: 10.1161/01.res.58.5.692. [DOI] [PubMed] [Google Scholar]
  7. Dilsizian V., Bonow R. O. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation. 1993 Jan;87(1):1–20. doi: 10.1161/01.cir.87.1.1. [DOI] [PubMed] [Google Scholar]
  8. Dostal D. E., Baker K. M. Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart. Mediation by the AT1 receptor. Am J Hypertens. 1992 May;5(5 Pt 1):276–280. doi: 10.1093/ajh/5.5.276. [DOI] [PubMed] [Google Scholar]
  9. Dzau V. J. Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med. 1993 Apr 26;153(8):937–942. [PubMed] [Google Scholar]
  10. Hirsch A. T., Talsness C. E., Schunkert H., Paul M., Dzau V. J. Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res. 1991 Aug;69(2):475–482. doi: 10.1161/01.res.69.2.475. [DOI] [PubMed] [Google Scholar]
  11. Hutchins G. M., Bulkley B. H. Infarct expansion versus extension: two different complications of acute myocardial infarction. Am J Cardiol. 1978 Jun;41(7):1127–1132. doi: 10.1016/0002-9149(78)90869-x. [DOI] [PubMed] [Google Scholar]
  12. Katz A. M. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N Engl J Med. 1990 Jan 11;322(2):100–110. doi: 10.1056/NEJM199001113220206. [DOI] [PubMed] [Google Scholar]
  13. Le Noble F. A., Schreurs N. H., van Straaten H. W., Slaaf D. W., Smits J. F., Rogg H., Struijker-Boudier H. A. Evidence for a novel angiotensin II receptor involved in angiogenesis in chick embryo chorioallantoic membrane. Am J Physiol. 1993 Feb;264(2 Pt 2):R460–R465. doi: 10.1152/ajpregu.1993.264.2.R460. [DOI] [PubMed] [Google Scholar]
  14. Lee Y. A., Lindpaintner K. The cardiac renin-angiotensin system. From basic research to clinical relevance. Arzneimittelforschung. 1993 Feb;43(2A):201–206. [PubMed] [Google Scholar]
  15. Lindpaintner K., Lu W., Neidermajer N., Schieffer B., Just H., Ganten D., Drexler H. Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat. J Mol Cell Cardiol. 1993 Feb;25(2):133–143. doi: 10.1006/jmcc.1993.1017. [DOI] [PubMed] [Google Scholar]
  16. Litwin S. E., Litwin C. M., Raya T. E., Warner A. L., Goldman S. Contractility and stiffness of noninfarcted myocardium after coronary ligation in rats. Effects of chronic angiotensin converting enzyme inhibition. Circulation. 1991 Mar;83(3):1028–1037. doi: 10.1161/01.cir.83.3.1028. [DOI] [PubMed] [Google Scholar]
  17. Lompré A. M., Mercadier J. J., Schwartz K. Changes in gene expression during cardiac growth. Int Rev Cytol. 1991;124:137–186. doi: 10.1016/s0074-7696(08)61526-0. [DOI] [PubMed] [Google Scholar]
  18. Martorana P. A., Kettenbach B., Breipohl G., Linz W., Schölkens B. A. Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist. Eur J Pharmacol. 1990 Jul 3;182(2):395–396. doi: 10.1016/0014-2999(90)90301-l. [DOI] [PubMed] [Google Scholar]
  19. Martorana P. A., Linz W., Schölkens B. A. Does bradykinin play a role in the cardiac antiischemic effect of the ACE-inhibitors? Basic Res Cardiol. 1991 Jul-Aug;86(4):293–296. doi: 10.1007/BF02191526. [DOI] [PubMed] [Google Scholar]
  20. Michel J. B., Lattion A. L., Salzmann J. L., Cerol M. L., Philippe M., Camilleri J. P., Corvol P. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res. 1988 Apr;62(4):641–650. doi: 10.1161/01.res.62.4.641. [DOI] [PubMed] [Google Scholar]
  21. Olivetti G., Lagrasta C., Ricci R., Sonnenblick E. H., Capasso J. M., Anversa P. Long-term pressure-induced cardiac hypertrophy: capillary and mast cell proliferation. Am J Physiol. 1989 Dec;257(6 Pt 2):H1766–H1772. doi: 10.1152/ajpheart.1989.257.6.H1766. [DOI] [PubMed] [Google Scholar]
  22. Olivetti G., Ricci R., Anversa P. Hyperplasia of myocyte nuclei in long-term cardiac hypertrophy in rats. J Clin Invest. 1987 Dec;80(6):1818–1821. doi: 10.1172/JCI113278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pfeffer J. M., Pfeffer M. A., Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res. 1985 Jul;57(1):84–95. doi: 10.1161/01.res.57.1.84. [DOI] [PubMed] [Google Scholar]
  24. Pfeffer M. A., Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990 Apr;81(4):1161–1172. doi: 10.1161/01.cir.81.4.1161. [DOI] [PubMed] [Google Scholar]
  25. Pfeffer M. A., Pfeffer J. M., Steinberg C., Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation. 1985 Aug;72(2):406–412. doi: 10.1161/01.cir.72.2.406. [DOI] [PubMed] [Google Scholar]
  26. Raya T. E., Gay R. G., Aguirre M., Goldman S. Importance of venodilatation in prevention of left ventricular dilatation after chronic large myocardial infarction in rats: a comparison of captopril and hydralazine. Circ Res. 1989 Feb;64(2):330–337. doi: 10.1161/01.res.64.2.330. [DOI] [PubMed] [Google Scholar]
  27. Samuel J. L., Barrieux A., Dufour S., Dubus I., Contard F., Koteliansky V., Farhadian F., Marotte F., Thiéry J. P., Rappaport L. Accumulation of fetal fibronectin mRNAs during the development of rat cardiac hypertrophy induced by pressure overload. J Clin Invest. 1991 Nov;88(5):1737–1746. doi: 10.1172/JCI115492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Schoemaker R. G., Debets J. J., Struyker-Boudier H. A., Smits J. F. Delayed but not immediate captopril therapy improves cardiac function in conscious rats, following myocardial infarction. J Mol Cell Cardiol. 1991 Feb;23(2):187–197. doi: 10.1016/0022-2828(91)90105-u. [DOI] [PubMed] [Google Scholar]
  29. Schorb W., Booz G. W., Dostal D. E., Conrad K. M., Chang K. C., Baker K. M. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res. 1993 Jun;72(6):1245–1254. doi: 10.1161/01.res.72.6.1245. [DOI] [PubMed] [Google Scholar]
  30. Schwartz K., Boheler K. R., de la Bastie D., Lompre A. M., Mercadier J. J. Switches in cardiac muscle gene expression as a result of pressure and volume overload. Am J Physiol. 1992 Mar;262(3 Pt 2):R364–R369. doi: 10.1152/ajpregu.1992.262.3.R364. [DOI] [PubMed] [Google Scholar]
  31. Shekhonin B. V., Guriev S. B., Irgashev S. B., Koteliansky V. E. Immunofluorescent identification of fibronectin and fibrinogen/fibrin in experimental myocardial infarction. J Mol Cell Cardiol. 1990 May;22(5):533–541. doi: 10.1016/0022-2828(90)90955-2. [DOI] [PubMed] [Google Scholar]
  32. Simpson P. Stimulation of hypertrophy of cultured neonatal rat heart cells through an alpha 1-adrenergic receptor and induction of beating through an alpha 1- and beta 1-adrenergic receptor interaction. Evidence for independent regulation of growth and beating. Circ Res. 1985 Jun;56(6):884–894. doi: 10.1161/01.res.56.6.884. [DOI] [PubMed] [Google Scholar]
  33. Smits J. F., van Krimpen C., Schoemaker R. G., Cleutjens J. P., Daemen M. J. Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content. J Cardiovasc Pharmacol. 1992;20(5):772–778. [PubMed] [Google Scholar]
  34. Swedberg K., Held P., Kjekshus J., Rasmussen K., Rydén L., Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) N Engl J Med. 1992 Sep 3;327(10):678–684. doi: 10.1056/NEJM199209033271002. [DOI] [PubMed] [Google Scholar]
  35. Sweet C. S., Emmert S. E., Stabilito I. I., Ribeiro L. G. Increased survival in rats with congestive heart failure treated with enalapril. J Cardiovasc Pharmacol. 1987 Dec;10(6):636–642. doi: 10.1097/00005344-198712000-00005. [DOI] [PubMed] [Google Scholar]
  36. Tsutsui H., Ishihara K., Cooper G., 4th Cytoskeletal role in the contractile dysfunction of hypertrophied myocardium. Science. 1993 Apr 30;260(5108):682–687. doi: 10.1126/science.8097594. [DOI] [PubMed] [Google Scholar]
  37. Weber K. T., Anversa P., Armstrong P. W., Brilla C. G., Burnett J. C., Jr, Cruickshank J. M., Devereux R. B., Giles T. D., Korsgaard N., Leier C. V. Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol. 1992 Jul;20(1):3–16. doi: 10.1016/0735-1097(92)90130-f. [DOI] [PubMed] [Google Scholar]
  38. Weber K. T., Brilla C. G. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991 Jun;83(6):1849–1865. doi: 10.1161/01.cir.83.6.1849. [DOI] [PubMed] [Google Scholar]
  39. van Krimpen C., Smits J. F., Cleutjens J. P., Debets J. J., Schoemaker R. G., Struyker Boudier H. A., Bosman F. T., Daemen M. J. DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: effects of captopril. J Mol Cell Cardiol. 1991 Nov;23(11):1245–1253. doi: 10.1016/0022-2828(91)90082-w. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES